Functional impact on adults and older people after hospitalization by Covid-19

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Citação
PHYSIOTHERAPY RESEARCH INTERNATIONAL, v.28, n.2, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and Objectives Hospitalization by Covid-19 can cause persistent functional consequences after hospital discharge due to direct and indirect effects of SARS-COV-2 in several organs and systems of the body added to post-intensive care syndrome and prolonged bed rest. These impacts can lead to dependency in activities of daily living, mainly in older people due to aging process and functional decline. This study aimed to compare the effects of hospitalization by Covid-19 on functional capacity of adults and older people and to identify its associated factors. Methods Cross-sectional observational study of 159 survivors of hospitalization by Covid-19 after 1 month from discharge at Hospital das Clinicas of the University of Sao Paulo, divided into groups: adults (aged < 60 years) and older people (aged >= 60 years). Those who did not accept to participate, without availability or without ability to understand the questionnaires were excluded. Functional capacity was assessed by the Barthel Index and patients were classified according to their scores. Data analysis was performed in JASP Statistics program and the sample was compared between the age groups. Wilcoxon test was applied to compare before and after periods, Mann-Whitney test was used for between groups comparison. We adopted alpha = 0.05. Results The total Barthel Index median score was lower 1 month after hospital discharge than in the pre-Covid-19 period. Older people had worse functional status than adults before and also showed greater impairment after hospital discharge. Both groups showed lower Barthel Index classification than before, and older people presented more functional dependence than adults in both periods. Age, sarcopenia and frailty were associated factors. Discussion Hospitalization by Covid-19 impacts functional capacity after 1 month from discharge, especially in older people. Age, sarcopenia and frailty are associated factors. These results suggest need for care and rehabilitation of Covid-19 survivors.
Palavras-chave
activities of daily living, Covid-19, functional capacity, hospitalization
Referências
  1. Bayat M, 2022, PHYSIOTHER RES INT, V27, DOI 10.1002/pri.1965
  2. Belli S, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02096-2020
  3. de Godoy CG, 2021, CLINICS, V76, DOI 10.6061/clinics/2021/e3030
  4. Silva ECGE, 2022, CLINICS, V77, DOI 10.1016/j.clinsp.2022.100075
  5. Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8
  6. Harrison AG, 2020, TRENDS IMMUNOL, V41, P1100, DOI 10.1016/j.it.2020.10.004
  7. Heyns A, 2021, EUR GERIATR MED, V12, P741, DOI 10.1007/s41999-021-00486-4
  8. Hippisley-Cox J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2244
  9. Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8
  10. Huang JQ, 2021, BMC PULM MED, V21, DOI 10.1186/s12890-021-01487-6
  11. Latronico N, 2022, THORAX, V77, P300, DOI 10.1136/thoraxjnl-2021-218064
  12. Liu DF, 2022, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.736109
  13. Luo XH, 2021, SCAND J IMMUNOL, V93, DOI 10.1111/sji.12989
  14. Machhi J, 2020, J NEUROIMMUNE PHARM, V15, P359, DOI 10.1007/s11481-020-09944-5
  15. MAHONEY F I, 1965, Md State Med J, V14, P61
  16. Malik P, 2022, J MED VIROL, V94, P253, DOI 10.1002/jmv.27309
  17. Malmstrom TK, 2013, J AM MED DIR ASSOC, V14, P531, DOI 10.1016/j.jamda.2013.05.018
  18. Meo SA, 2021, EUR REV MED PHARMACO, V25, P8012, DOI 10.26355/eurrev_202112_27652
  19. Morley D, 2012, EUR J NEUROL, V19, P927, DOI 10.1111/j.1468-1331.2011.03592.x
  20. Minosso JSM, 2010, ACTA PAUL ENFERM, V23, P218, DOI 10.1590/S0103-21002010000200011
  21. Musheyev B, 2021, J INTENSIVE CARE, V9, DOI 10.1186/s40560-021-00542-y
  22. Nakanishi N, 2021, J CLIN MED, V10, DOI 10.3390/jcm10173870
  23. Piotrowicz K, 2021, AGING CLIN EXP RES, V33, P2887, DOI 10.1007/s40520-021-01942-8
  24. Pizarro-Pennarolli C, 2021, PEERJ, V9, DOI 10.7717/peerj.11026
  25. Qin ES, 2022, PM&R, V14, P173, DOI 10.1002/pmrj.12716
  26. Ramos-Rincon JM, 2021, J GERONTOL A-BIOL, V76, pE28, DOI 10.1093/gerona/glaa243
  27. Rodrigues MK, 2021, J FRALITY AGING, V10, P38, DOI 10.14283/jfa.2020.7
  28. Rousseau AF, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-021-00910-9
  29. SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6
  30. Shanbehzadeh S, 2021, J PSYCHOSOM RES, V147, DOI 10.1016/j.jpsychores.2021.110525
  31. Shi S, 2021, J AM MED DIR ASSOC, V22, P1138, DOI 10.1016/j.jamda.2021.04.003
  32. Siqueira AB, 2004, REV SAUDE PUBL, V38, P687, DOI 10.1590/S0034-89102004000500011
  33. Soares MN, 2022, J CACHEXIA SARCOPENI, V13, P11, DOI 10.1002/jcsm.12896
  34. Walle-Hansen MM, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-021-02140-x
  35. Wang MY, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.587269
  36. Wierdsma NJ, 2021, CLIN NUTR ESPEN, V43, P369, DOI 10.1016/j.clnesp.2021.03.021
  37. Yong SJ, 2021, INFECT DIS-NOR, V53, P737, DOI 10.1080/23744235.2021.1924397